The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Failure of Macrolide Antibiotic Treatment in Patients with Bacteremia Due to Erythromycin‐Resistant Streptococcus pneumoniae
Open accessAbstract
The rate of macrolide resistance among Streptococcus pneumoniae is increasing, but some investigators have questioned its clinical relevance. We conducted a matched case-control study of patients with bacteremic pneumococcal infection at 4 hospitals to determine whether development of breakthrough bacteremia during macrolide treatment was related to macrolide susceptibility of the pneumococcal isolate. Case patients (n=86) were patients who had pneumococcal bacteremia and an isolate that was either resistant or intermediately resistant to erythromycin. Controls (n=141) were patients matched for age, sex, location, and year that bacteremia developed who had an erythromycin-susceptible pneumococcus isolated. Excluding patients with meningitis, 18 (24%) of 76 case patients and none of 136 matched controls were taking a macrolide when blood was obtained for culture (P=.00000012). Moreover, 5 (24%) of 21 case patients with the low-level-resistant M phenotype and none of 40 controls were taking a macrolide (P=.00157). These data show that development of breakthrough bacteremia during macrolide or azalide therapy is more likely to occur among patients infected with an erythromycin-resistant pneumococcus, and they also indicate that in vitro macrolide resistance resulting from both the efflux and methylase mechanisms is clinically relevant.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically
Ferraro, M. J. (2000) · Cited by 16,875
National Committee for Clinical Laboratory Standards
Bruck, E. (1980) · Pediatrics · doi:10.1542/peds.65.1.187 · Cited by 14,751
Infectious Diseases Society of America
Enders, J. F. (1969) · Journal of Infectious Diseases · doi:10.1093/infdis/119.3.317 · Cited by 3,286
Practice Guidelines for the Management of Community-Acquired Pneumonia in Adults
Bartlett, J. G., Dowell, S. F., Mandell, L. A., File, T. M., Musher, D. M., & Fine, M. J. (2000) · Clinical Infectious Diseases · doi:10.1086/313954 · Cited by 2,286
Niederman, M. S., Mandell, L. A., Anzueto, A., Bass, J. B., Broughton, W. A., Campbell, G. D., Dean, N., File, T., Fine, M. J., Gross, P. A., et al. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.163.7.at1010 · Cited by 2,150
Detection of erythromycin-resistant determinants by PCR
Sutcliffe, J., Grebe, T., Tait-Kamradt, A., & Wondrack, L. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.11.2562 · Cited by 989
Pneumococcal Bacteremia with Especial Reference to Bacteremic Pneumococcal Pneumonia
AUSTRIAN, R., & GOLD, J. (1964) · Annals of Internal Medicine · doi:10.7326/0003-4819-60-5-759 · Cited by 923
Mandell, L. A., Marrie, T. J., Grossman, R. F., Chow, A. W., Hyland, R. H., & and the Canadian Community-Acquired Pneumonia Working Group (2000) · Clinical Infectious Diseases · doi:10.1086/313959 · Cited by 664
Bacterial resistance to macrolide, lincosamide, and streptogramin antibiotics by target modification
Leclercq, R., & Courvalin, P. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.7.1267 · Cited by 628
Sutcliffe, J., Tait-Kamradt, A., & Wondrack, L. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.8.1817 · Cited by 619
Heffelfinger, J. D. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.10.1399 · Cited by 610
Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance, 1995-1997
(2000) · American Journal of Public Health · doi:10.2105/ajph.90.2.223 · Cited by 589
The Prevalence of Drug-Resistant Streptococcus pneumoniae In Atlanta
Hofmann, J., Cetron, M. S., Farley, M. M., Baughman, W. S., Facklam, R. R., Elliott, J. A., Deaver, K. A., & Breiman, R. F. (1995) · New England Journal of Medicine · doi:10.1056/nejm199508243330803 · Cited by 503
Macrolide Resistance Among Invasive <EMPH TYPE="ITAL">Streptococcus pneumoniae</EMPH> Isolates
Hyde, T. B. (2001) · JAMA · doi:10.1001/jama.286.15.1857 · Cited by 315
Tait-Kamradt, A., Davies, T., Appelbaum, P. C., Depardieu, F., Courvalin, P., Petitpas, J., Wondrack, L., Walker, A., Jacobs, M. R., & Sutcliffe, J. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.12.3395-3401.2000 · Cited by 260
Breakthrough Pneumococcal Bacteremia in Patients Being Treated with Azithromycin and Clarithromycin
Kelley, M. A., Weber, D. J., Gilligan, P., & Cohen, M. S. (2000) · Clinical Infectious Diseases · doi:10.1086/318157 · Cited by 234
Bacteremic and Nonbacteremic Pneumococcal Pneumonia A Prospective Study
Musher, D. M., Alexandraki, I., Graviss, E. A., Yanbeiy, N., Eid, A., Inderias, L. A., Phan, H. M., & Solomon, E. (2000) · Medicine · doi:10.1097/00005792-200007000-00002 · Cited by 217
Shortridge, V. D., Doern, G. V., Brueggemann, A. B., Beyer, J. M., & Flamm, R. K. (1999) · Clinical Infectious Diseases · doi:10.1086/313452 · Cited by 178
Granizo, J. J. (2000) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/46.5.767 · Cited by 173
Pneumococcal macrolide resistance—myth or reality?
Amsden, G. W. (1999) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/44.1.1 · Cited by 169
Gay, K., Baughman, W., Miller, Y. K., et al. (2000) · The Journal of Infectious Diseases · doi:10.1086/315853 · Cited by 126
Fatal Pneumococcal Pneumonia Attributed to Macrolide Resistanceand Azithromycin Monotherapy
WATERER, G. W., Wunderink, R. G., & Jones, C. B. (2000) · CHEST Journal · doi:10.1378/chest.118.6.1839-a · Cited by 93
Moreno, S., García-Leoni, M. E., Cercenado, E., Díaz, M. D., de Quirós, J. C. L. B., & Bouza, E. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/20.5.1195 · Cited by 88
Matched Case-Control Studies with a Variable Number of Controls per Case
Walter, S. D. (1980) · Journal of the Royal Statistical Society Series C (Applied Statistics) · doi:10.2307/2986303 · Cited by 43
PNEUMOCOCCAL MENINGITIS DURING THERAPY OF OTITIS MEDIA WITH CLARITHROMYCIN
Reid, R. T., Bradley, J. S., & Hindler, J. A. (1995) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199512000-00016 · Cited by 38
Cited by
Mandell, L. A., Wunderink, R. G., Anzueto, A., Bartlett, J. G., Campbell, G. D., Dean, N. C., Dowell, S. F., File, T. M., Musher, D. M., Niederman, M. S., et al. (2007) · Clinical Infectious Diseases · doi:10.1086/511159 · Cited by 6,202
Metlay, J. P., Waterer, G. W., Long, A. C., Anzueto, A., Brozek, J., Crothers, K., Cooley, L. A., Dean, N. C., Fine, M. J., Flanders, S. A., et al. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201908-1581st · Cited by 3,657
Mandell, L. A., Bartlett, J. G., Dowell, S. F., File, T. M., Musher, D. M., & Whitney, C. (2003) · Clinical Infectious Diseases · doi:10.1086/380488 · Cited by 1,004
Guidelines for the management of adult lower respiratory tract infections - Full version
Woodhead, M., Blasi, F., Ewig, S., Garau, J., Huchon, G., Ieven, M., Ortqvist, A., Schaberg, T., Torres, A., van der Heijden, G., et al. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03672.x · Cited by 942
Self-citationGuidelines for the management of adult lower respiratory tract infections
Woodhead, M., Blasi, F., Ewig, S., Huchon, G., Leven, M., Ortqvist, A., Schaberg, T., Torres, A., van der Heijden, G., & Verheij, T. J. M. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00055705 · Cited by 895
Metadata
- Authors
- Lonks, J. R., Garau, J., Gomez, L., Xercavins, M., Ochoa de Echagüen, A., Gareen, I. F., Reiss, P. T., & Medeiros, A. A.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2002-09
- Volume
- 35
- Issue
- 5
- Pages
- 556-564
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2100059020
- Cited by
- 324
- References
- 25
- FWCI
- 32.80
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.